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1. Introduction
  Diabetic mellitus is a kind of metabolism disorder disease 
which threatened human’s health severely. It is listed as 
one of the three most dangerous diseases worldwide by the 
world health organization[1,2]. The chronic raising of blood 
glucose level caused by diabetic mellitus can lead to a 
series of complications[3]. Among them, the cardiovascular 
complication is the leading cause of death. There’s evidence 
that microvascular injury plays a very important role in the 
diabetic cardiovascular dysfunction[4].
  The microvascular located at the terminal of the 
circulation, and it determined the myocardial perfusion 
level and the coronary reserve to some extent. Microvascular 
injury may also responsible for complications such as 
microvascular angina, adiabetic cardiomyopathy, no-reflow 
phenomena after the percutsneous coronary interventional 
and myocardial ischemia-reperfusion[5]. Clinical studies 
indicate that the microvascular injury happened much 
earlier than the damage of large vessels and myocardial 
cells. Some scholars deemed that finding the effective 
targeting point to alleviate the microvascular injury is 
of great importance to the prognosis of diabetic mellitus 
patients[6]. Recent studies have showed that the glucagon 
like peptide 1 (GLP-1) can protect pancreas by lowering the 
blood glucose level, and it also of benefit to cardiovascular 
functions such as alleviating the injury caused by 
myocardial ischemia-reperfusion, promoting the recovery 
of the ventricular function[7,8]. The native GLP-1 can’t be 
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used in the treatment of diabetic mellitus due to its short 
half-life; however, the much long lasting GLP-1 analogue 
has been widely used as hypoglycemic agent in clinic[9,10]. 
Nowadays, the function of GLP-1 has become more and 
more clear, but the specific molecular mechanism of how it 
affected the myocardial microvascular is still unclear. The 
unclearness also restricted the application of GLP-1 on the 
cardiovascular complications of diabetes.
  In this research, we studied the protective effort of GLP-
1on the myocardial microvascular of rats from the cellular 
level. The molecular mechanism was also studied which 
may provided theoretical support for the treatment of 
cardiovascular complication in diabetic mellitus.
2. Materials and methods
2.1. Material
  Reagents: GLP-1 (Tocris Bioscience), DMEM/low glucose 
(Hyclone), fetal calf serum (Zhejiang Tianhang Biological 
Technology), Dil-Ac-LDL (Molecular probe), Superoxide 
detection kit (Beyotime), NADPH activity detection kit 
(YouLi), Colorimetric TUNEL Apoptosis Assay (Roche), 
Superoxide anion detection kit (Beyotime), BCA Protein assay 
kit (Thermo), HRP-labeled sheep Anti-rabbit IgG (Beyotime), 
ECL chemiluminescence detection kit (Biolegend), etc were 
utilized in this study.
  Instrument: CO2 incubator (Thermo), western blot systerm 
(Bio-Rad), confocal microscope (Leica), etc were utilized in 
this study.
2.2. Isolation and culture of cardiac microvascular 
endothelial cells
  The cardiac microvascular endothelial cells were isolated 
from Sprague-Dawley rat heart by the enzyme dissociation 
method. Briefly, two weeks old SD rats were anesthetized 
by pentobarbital injection. The heart was removed from the 
rat under sterile conditions and then the left ventricular 
was isolated. After washed with PBS, the epicardial was 
removed and the remaining myocardium was then minced. 
The minced tissue was immersed in 0.2% collagenase in 
37 曟 for 10 minutes, and then 0.02% trypsin was added 
for another 10 minutes to digest the tissue. DMEM/low 
glucose with 10% FBS was added to stop digestion, and the 
solution was filtered through an 100 毺m nylon mesh to 
remove the undigested tissue. The solution was centrifuged, 
resuspended in DMEM/low glucose supplemented with 15% 
FBS and then seeded on dishes. After the cell was cultured 
in humidified environment at 37曟 and 5% CO2 for 72 h, 
the medium was exchanged. Thereafter, the medium was 
changed every 48 h and the cell was passaged when they 
reached the exponential phase. Cardiac microvascular 
endothelial cells (CMECs) were seeded in coverslips, 
acetylated low density lipoprotein (15 毺g/mg) was added 
when the cells reached about 80% confluence. After cultured 
together for 8 h, the coverslip was washed with PBS, fixed 
with 4% paraformaldehyde solution. The cells was incubated 
with DAPI (1:500) for 5 min, after washed with PBS, the 
coverslip was dried in the air and then followed by mounting 
with neutral glycerine and microscopic examination with a 
confocal microscopy.
2.3. Cell grouping for in vitro experiment
  CMECs were seeded in 6 well plates (1.5伊105 cells/well), 
and divided them into three groups, namely the control 
group, high glucose group, GLP-1 group and GLP-1 plus 
high glucose group. The final concentration of the glucose in 
the control group and the high glucose group were 5.5 mmol/
L and 25 mmol/L, respectively. The final concentration of 
GLP-1 was 10 nmol/L.
2.4. Index detection
2.4.1. Detection of reactive oxygen species
  CMECs were seeded in 96 well plates (5伊105 cells/well), 
as it reached about 80% confuluence, and the medium was 
discarded. After washed with PBS, the cell was incubated 
with superoxide detection working solution for 3 min, and 
then the optical density (450) was tested by a microplate 
reader.
2.4.2. Detection of superoxide anion
  CMECs were seeded in the coverslips when it reached 
80% confluence, after it attached, deal it as we described 
in the grouping part. Dihydroethidium (DHE 8 毺mol/L, in 
0.1% DMSO) was added in the medium, and then incubated 
for 1 h. After washed with PBS, DAPI (1:500) was added and 
followed by incubation at room temperature for 5 min. The 
coverslip was washed with PBS again and dried in the air 
and then followed by mounting with neutral glycerine and 
microscopic examination with a confocal microscopy. If the 
red fluorescence was enhanced, it suggested the level of 
superoxide anion was elevated.
  CMECs were seeded in 6 well plates (1.5伊105 cells/well), 
after it attached, deal it as we described in the grouping 
part. TRIzol was added to lyse the cell, and placed at 
-70 曟 for further use. NADPH peroxidase activity was 
detected using a chemiluminescence apparatus according 
to the instruction of the kit. The activity of the NADPH 
peroxidase was computed by the formulation: RLU the real 
activity of the sample=RLUtotal activity of the sample-RLUspecific activity of 
the sample-RLUcontrol group.
2.4.3. Detection of apoptosis
  CMECs were seeded in the coverslips when it reached 80% 
confluence, after it attached, deal it as we described in the 
grouping part. The coverslips was fetched out, washed with 
PBS, and then fixed in 4% paraformaldehyde. After washed 
with PBS, 3% hydrogen peroxide was added and incubated 
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for 20 min to remove the endogenous peroxidase. Triton 
100 was added and then put on the ice. Before and after the 
Triton 100 was added, the coverslips should be washed with 
PBS carefully. The apoptosis rate of the CMECs was detected 
by using the TUNEL apoptosis detection kit, and the working 
liquid was prepared according to the instruction. Briefly, the 
working liquid was dropwise added onto the coverslips, after 
incubated in 37 曟 for 1 h. Then it was washed with PBS, 
and the cells were incubated with DAPI (1:500) for 5 min at 
room temperature. It was washed with PBS again, and then 
followed by mounting and microscopic examination.
2.4.4. Molecular mechanism of GLP-1 on CMECs
  CMECs were seeded in 6 well plates (1.5伊105 cells/well), 
after it attached. They were divided into 6 groups, namely 
control group, high glucose group, GLP-1 plus high glucose 
group, GLP-1 plus H89 plus high glucose group, fasudil plus 
high glucose group and GLP-1 plus fasudil plus high glucose 
group. Western blot was used to detect the expression level 
of Rho and ROCK. Briefly, the cell was washed with PBS and 
then, M2 was added and the plate was left on ice for 30 min 
to lyse the cell. Cells were collected into a centrifuge tube 
with a cell scraper, and then lysed with ultrasonic irradiation 
for 3 s, 2 times. Cell debris was removed by centrifugation 
of the lysates at 12 000 g for 2 minat 4 曟, and protein
concentration was determined by using the BCA Protein 
assay kit. The working liquid was prepared according to 
the instruction, and the standard curve was made, the 
plate was incubated in 37 曟 for half an hour, and then the 
optical density (570) was tested by a microplate reader, and 
finally the protein concentration was computed according 
to the standard curve. All the specimen were adjusted to 
the same concentration, after the protein supernate was 
mixed with the buffer, the liquid was boiled for 10 min, 
followed by cooling, centrifugation, 12% SDS-PAGE and the 
protein was transferred to nitrocellulose membrane. The 
membrane was then washed and incubated with goat anti- 
rabbit IgG for 60 min at room temperature. After washing, 
the chemiluminescence reagent was added and incubated 
together for 3 min. The protein was tested with an ECL 
western blot analysis detection system, and then the gray 
value was computed. 
2.5. Statistical analysis
  SPSS 17.0 software was used for statistical analysis in this 
study. All data are expressed as mean依SD, and t-test was 
were applied to perform statistical analysis. P<0.05 were 
considered significantly different.
3. Results
3.1. Culture and evaluation of CMECs
  The CMECs was spindle or polygonal shaped and displayed 
typical cobblestone-like morphology (Figure 1). DiL-Ac-
LDL phagocytic test showed that the cell can phagocytize 
DiL-Ac-LDL, which suggests that the cell we harvested in 
out experiment is CMECs.
Figure 1. Cobblestone-like CMECs isolated from rats.
3.2. Inhibition effect of GLP-1 on generation of ROS in 
CMECs 
  Figure 2 showed that CMECs in high glucose group 
produced more ROS than control group. Compared with the 
control group, the fluorescence intensity of CMECs in the 
high glucose group was greatly improved, while after added 
with GLP-1, the fluorescence intensity was declined clearly, 
and the difference were all statistically significant (P<0.05).
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Figure 2. Influence of GLP-1 on the generation of ROS in control 
group and high glucose group. 
A: There was no statistical difference between the levels of ROS in the 
control group before and after treated with GLP-1 (P>0.05). The level 
of ROS before treated with GLP-1was significantly higher than before 
in the high glucose group (P<0.05); B: After treated with GLP-1, the 
absorbance value of DHE was declined in both group, and there was 
no significant difference in the control group (P>0.05); the difference 
in the high glucose group was statistically significant, P<0.05.
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3.3. Inhibition effect of GLP-1 on activity of NADPH 
peroxidase in CMECs 
  Figure 3 showed the activity of NADPH peroxidase in 
CMECs was much higher in the high glucose group than the 
control group, the difference was statistically significant 
(P<0.05). After treated with GLP-1, the activity of NADPH 
peroxidase was declined significantly (P<0.05).
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Figure 3. Influence of GLP-1 on the activity of NADPH peroxidase.
The activity of NADPH peroxidase was higher in the high glucose 
group than in the control group. After treated with GLP-1, the activity 
of NADPH peroxidase was declined significantly (P<0.05).
3.4. Inhibition effect of GLP-1 on apoptosis of CMECs
  TUNEL staining result showed that the apoptosis rate of 
CMECs in the high glucose group was much higher than in 
the control group (11.20依2.64 vs. 40.06依2.81 P<0.05). After 
treated with GLP-1, the apoptosis rate of CMECs in the high 
glucose group was declined significantly, compared with 
group with normal glucose level [(40.06依2.81)% vs. (27.11依
2.62)%], P<0.05).
3.5. Suppressive effect of GLP-1 on activation of Rho/ROCK 
through cAMP/PKA pathway in CMECs
  Compared with the control group, the expression level of 
Rho/ROCK was improved significantly in the high glucose 
group. After treated the cell with GLP-1, the expression 
level of Rho/ROCK was declined greatly, and the difference 
were all statistically significant (P<0.05). When we combined 
GLP-1 and PKA inhibitor H89, there was some improvement 
in the expression level of Rho/ROCK (P<0.05). As showed in 
the former experiment, GLP-1 can decrease the expression 
level of ROS induced by high glucose in CMECs; treated the 
cell with Rho inhibitor fasudil can suppress the expression 
of ROS induced by high glucose, while when used GLP-1 
and fasudil together, there were no significant difference 
in the expression level of ROS compared with GLP-1 used 
alone (Figure 4).
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Figure 4. Influence of GLP-1 on activity of Rho/ROCK in CMEMs 
through cAMP/PKA pathway.
A, B: High glucose induced the expression of Rho and ROCK; 
when treated with GLP-1, the level of Rho and ROCK was declined 
significantly (P<0.05); when GLP-1 and H89 were added together, the 
level of Rho and ROCK was improved significantly compared with the 
GLP-1 treated group (P<0.05). C: CMECs in the high glucose group 
treated with GLP-1, fasudil, and GLP-1 plus fasudil can significantly 
lower the level of ROS, compared with the untreated group (P<0.05).
 
4. Discussion
  In this study, we isolated and cultured CMECs from rats in 
vitro, and observed the protective effort of GLP-1 on CMECs 
under high glucose, and tried to elucidate the molecular 
mechanism of protective effort. We found that GLP-1 can 
lower the expression level of ROS, NADPH peroxidase, Rho 
and ROCK in CMECs exposed to high glucose. The results 
further confirmed that GLP-1 can inhibit the oxidative stress 
effort and apoptosis of CMECs, and it is achieved by cAMP/
PKA/Rho signaling pathway 
  GLP-1is a kind of transmembrane G-protein-coupled 
receptor made up of 463 amino acids. It is produced by L 
cells present in the mucosa of the distal small intestine 
and the colon which is wildly spread in the organs such 
as pancreas, gastrointestinal, kidney and brain[11,12]. 
GLP-1 is considered as an ideal drug for the treatment of 
diabetes as it can regulate glucose levels by stimulating 
glucose dependent insulin secretion and biosynthesis, 
and by promoting the prolification of beta cells in the 
pancreas, suppressing glucagon secretion, delaying gastric 
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emptying[13]. Betsy et al[14] found by animal experiment 
that GLP-1 can improve the function of myocardial 
microcirculation after CPR with no increase of ventricular 
fibrillation. Lesven et al[15] also found that GLP-1 can 
ameliorate clinical symptoms effectively when it used in the 
acute phase of amyocardia. Nowadays, GLP-1 analogues 
has been widely used clinically for its advantages in all the 
aspects, and has achieved satisfactory curative effect[16,17]. 
But how GLP-1 exerts a protective function in the cell level 
is still unclear. CMEC is the most common cell line used 
in the laboratory to study the cardiovascular disease. The 
shape, structure and function of CMECs is quiet different 
from endothelial cells in the large vessels for the force 
(sheer stress, blood perfusion pressure and the extrusion in 
myocardial contraction) applied on it[18].
  Studies showed that the organism will generate a great deal 
of free radicals under the stimulation of high glucose, and 
then start the oxidative stress reaction[19,20]. Some animal 
experiment suggested tissues in mouse with spontaneous 
diabetes are under different state of oxidative stress. The 
level of lipid peroxide in the liver, heart and kidney of rats 
with STZ induced diabetes also rose obviously[21,22]. Teodoro 
et al[23] found in their cell experiment that, exposed the 
HepG2 to high glucose less than an hour, the damage of 
mitochondria can be observed, and the level of NADH and 
the marker of oxidative stress ROS also improved greatly. In 
our experiment, we discovered that high glucose can induce 
the over expression of ROS in CMECs, while when GLP-1 
was added, ROS declined obviously. The results suggested 
that GLP-1 can suppress the oxidative stress induced by 
high glucose to some degree. NADPH peroxidase is the main 
resource of ROS produced by endothelial cells; therefore, we 
detected the level of NADPH peroxidase to further verify our 
results and also found GLP-1 can obviously suppress the 
activation of NADPH peroxidase induced by high glucose.
  Oxidative stress is the initial factor of vascular 
complications of diabetis. Cells exposed to high glucose will 
generate a great deal of ROS, activate a series of biological 
efforts such as cell prolification, apoptosis, migration 
and inflammatory response. Those biological efforts will 
damage the vascular endothelial cell, increase the vascular 
permeability, lead to the pathological angiogenesis and 
the disorder of angiokinesis, which may results in vascular 
complications of diabetis finally[24,25]. In our study, we 
also discovered high glucose can improve the activation of 
caspase 3 in CMECs, and improve the apoptosis rate. All 
of this lead to the conclusion that the anti-oxidative stress 
effort of GLP-1 can inhibits the apoptosis of CMECs.
  Several stimuli can activate the Rho/ROCK pathway, and it 
can interact with some other signaling pathways, and then 
regulate the transcription of some specific genes[26]. Lin et 
al[27] discovered that the cardiovascular injuries were much 
lighter in the diabetic rats with ROCK 1 deficiency than the 
wild type. Which means lower the activation of ROCK and 
arginine can improve the function of cardiovascular system 
in diabetic. In our experiment, high glucose can induce 
the over expression of Rho/ROCK in CMECs, while when 
the GLP-1 was added, the level of Rho/ROCK declined 
obviously. The phenomenon suggested that GLP-1 exert the 
anti-oxidative stress effort through inhibiting the expression 
of Rho/ROCK. In addition, we found, when the cell treated 
with PKA inhibitor H89, the level of Rho/ROCK declined 
obviously. This indicate that GLP-1 suppress the expression 
of Rho/ROCK through cAMP/PKA pathway, and further 
inhibit the oxidative stress effort. GLP-1 can combined 
with GLP-1R in the membrane of pancreatic 毬-cell, 
thus improve the intracellular cAMP level, and the voltage 
dependent calcium channel opened, induce the influx 
of extracellular Ca2+, and stimulate the insulin secretion. 
GLP-1 can inhibit the inflammatory effort through cAMP/
PKA pathway, and thus attenuates endothelial dysfunction 
induced by lipopolysaccharide[28,29]. We can infer cAMP/
PKA is a major pathway for the protective effort of GLP-1. 
At last we detected the influence of H89 on the generation 
of ROS, we discovered, H89 can reduce the anti-oxidative 
stress effort of GLP-1. The results suggested that the 
protective effort of GLP-1 on CMECs is achieved by cAMP/
PKA/Rho signaling pathway. 
  There were flaws in our research. In our study, we only 
conducted cell experiment, and the animal experiment is 
still needed in the future.
  In conclusion, GLP-1 can inhibit the oxidative stress effort 
and apoptosis of CMECs, and it is achieved by cAMP/PKA/
Rho signaling pathway. 
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